Author Archives: Viatcheslav Vlassov
Recent Posts
- Dosing begins in trial of AlloNK, NK cell therapy for lupus nephritis
- Lupus consortium partners with FDA on cell therapies
- Study: Depression is largely prevalent, but undiagnosed in SLE
- FDA clears off-the-shelf CB-010 cell therapy for lupus nephritis trial
- Itolizumab reduces urine protein levels in Phase 1B clinical trial